Dreamgenics 
The term Diabetes Mellitus (DM) describes a complex metabolic disorder characterized by chronic hyperglycemia as a result of insufficient insulin secretion and/or decreased tissue response to insulin, resulting in abnormally high blood glucose concentrations. The etiology of the disease is very ... Read More
Today, March 31, is World Colon Cancer Day, with the aim of raising awareness of the need to adopt healthy habits for the prevention of this tumor, as well as the importance of its early diagnosis. More than 37,000 people a year are diagnosed with colorectal cancer in our country, being the most common cause of ... Read more
APACI and Dreamgenics have signed a framework agreement of institutional collaboration to promote the genetic diagnosis of congenital cardiovascular diseases, as well as to develop research projects and training activities related to them. The Asociación de Padres y Amigos de Cardiopatías Congénitas (APACI) is an association of public utility, national and independent that watches over and promotes the ... Read more
Cardiovascular diseases (CVD) are diseases that affect the heart and blood vessels and are the leading cause of death worldwide with about 520 million people affected. CVDs include numerous and diverse pathologies, some of which are better known, such as myocardial infarction, heart failure or heart failure.... Read more
The United Nations General Assembly decided to proclaim in 2016, February 11 as the International Day of Women and Girls in Science. The main objective of this day is to achieve greater participation and inclusion of women and girls in the world of science and technology, ... Read More
CNVs (Copy Number Variations) are a type of submicroscopic-sized structural variants, such as deletions, duplications, insertions, inversions and translocations, which involve a change in copy number with respect to the reference genome (Figure 1). Although they are relatively common in the structure of our genomes and contribute greatly to the variability ... Read More
Since its appearance just over a decade ago, we have witnessed how RNA-Seq technology has revolutionized our knowledge of the transcriptome. This methodology performs an estimation of gene expression based on the number of RNA fragments from sequencing that align with a given region of a genome ... Read More
The Foundation for Biosanitary Research and Innovation of Asturias (FINBA) and Dreamgenics have signed a framework agreement of institutional collaboration for the scientific-technological development and biosanitary innovation in Asturias with the aim of carrying out research projects in the field of Personalized Precision Medicine. FINBA has ... Read more
UMIs (Unique Molecular Identifiers), also known as "molecular barcodes", were first introduced in high-throughput sequencing or Next-generation Sequencing (NGS) experiments more than a decade ago. These codes consist of different short oligonucleotide sequences that are uniquely added to each DNA molecule prior to sequencing, and ... Read more
Dreamgenics has as a fundamental objective of its activity as a biotechnology company to collaborate in the development of Precision Medicine, and to achieve this, it is essential to establish close links with prestigious institutions and research centers. For this reason, it has reached a collaboration agreement with the European University. With this collaboration, both institutions will ... Read more